SCHEMBL2986153

SCHEMBL2986153

COC(=O)Cc1ccc(O)c(CNC(=O)OC(C)(C)C)c1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.51
GAA P10253 1/20 0.51
GFER P55789 1/20 0.51
HDAC1 Q13547 1/20 0.45
EGFR P00533 2/20 0.44
HSP90AB1 P08238 1/20 0.41
KDM4A O75164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
TLR7 Q9NYK1 2/20 0.40
KCNA5 P22460 1/20 0.40
GLS O94925 1/20 0.40
HPN P05981 1/20 0.39
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
NAMPT P43490 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15862359 0.90 GAA (0.43) ALDH1A1GAAGFERHDAC1HSP90AB1
SCHEMBL2987885 0.88 HDAC1 (0.51) ALDH1A1GAAHDAC1EGFRKDM4A
SCHEMBL4893909 0.88 HDAC1 (0.43) HDAC1EGFRKDM4AL3MBTL1HPN
SCHEMBL3413751 0.87 HDAC1 (0.49) ALDH1A1GAAGFERHDAC1EGFR
SCHEMBL20049680 0.84 CACNA1H (0.43) ALDH1A1GAAGFERKDM4AL3MBTL1
SCHEMBL5209897 0.82 L3MBTL1 (0.52) ALDH1A1GAAHDAC1KDM4AL3MBTL1
SCHEMBL8786913 0.80 GLS (0.57) KDM4AGLSNAMPT
SCHEMBL3934273 0.79 ITGA4 (0.52) ALDH1A1GAAGFEREGFRHSP90AB1
SCHEMBL8145260 0.79 ALDH1A1 (0.68) ALDH1A1GAAGFEREGFRHSP90AB1
SCHEMBL2985005 0.79 ALDH1A1 (0.40) ALDH1A1GAAGFERHDAC1KDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492437-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2013-07-23 US disclosed
EP-2057115-B9 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-12-26 EP disclosed
EP-2057115-B1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-10-03 EP disclosed
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2012-08-09 US disclosed
US-8183289-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2012-05-22 US disclosed
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2010-07-08 US disclosed
EP-2057115-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES Array Biopharma, Inc. (US) 2009-05-13 EP disclosed
WO-2008024746-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA, INC. (US) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 ALDH1A1 610/4885GAA 2523/4885GFER 3041/4885
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 ALDH1A1 610/4885GAA 2523/4885GFER 3041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.